We are live on ! Find out more
GNMK

GenMark Diagnostics, Inc
GNMK

Delisted

GNMK was delisted on the 21st of April, 2021.

Back to rankings

Fund managers haven’t disclosed any holdings of GNMK yet.

GNMK Hedge Fund Activity: Q2 2021 in Review

0 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in GenMark Diagnostics, Inc (GNMK) for Q2 2021, worth a combined $0 — down 100% from $1.62B a quarter earlier.

Sellers outnumbered buyers: 163 funds closed out of GNMK and 0 opened new positions — a net loss of 163 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Wasatch Advisors, exiting entirely with an estimated $176M sold.

  • 0 institutional investors held GenMark Diagnostics, Inc (GNMK) as of Q2 2021, down from 164 in Q1 2021.
  • Funds reported $0 of GenMark Diagnostics, Inc stock for Q2 2021, down 100% quarter-over-quarter.
  • 0 funds opened new GenMark Diagnostics, Inc positions in Q2 2021 and 163 closed out, a net change of -163 holders.
  • The largest GenMark Diagnostics, Inc seller in Q2 2021 was Wasatch Advisors, an estimated $176M sold.

Based on aggregated 13F filings for Q2 2021.